Clinical Trial Update: GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

GSK3739937's first-in-human Phase 1 study in healthy volunteers for HIV infection has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK3739937

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2023-08-23